Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2016, Article ID 4510483, 10 pages
http://dx.doi.org/10.1155/2016/4510483
Research Article

HIV-1 Evolutionary Patterns Associated with Metastatic Kaposi’s Sarcoma during AIDS

1Bioinfoexperts, LLC, 718 Bayou Lane, Thibodaux, LA 70302, USA
2Department of Pathology and Laboratory Medicine, University of Florida, 2055 Mowry Road, Gainesville, FL 32610, USA
3Natural Selection, Inc., 5910 Pacific Center Blvd., 6480 Weathers Place, San Diego, CA 92121, USA
4The AIDS and Cancer Specimen Resource, University of California at San Francisco and the Department of Laboratory Medicine, Pathology, and Medicine, University of California at San Francisco, 1001 Poterero Ave, Bldg 3, Rm 207, UCSF Box 1317, San Francisco, CA 94110, USA

Received 11 May 2016; Accepted 7 August 2016

Academic Editor: C. Verhoef

Copyright © 2016 Susanna L. Lamers et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Cook-Mozaffari, R. Newton, V. Beral, and D. P. Burkitt, “The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic,” British Journal of Cancer, vol. 78, no. 11, pp. 1521–1528, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Chang, E. Cesarman, M. S. Pessin et al., “Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma,” Science, vol. 266, no. 5192, pp. 1865–1869, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5710a2.htm.
  4. A. Stewart, S. Chan Carusone, K. To, N. Schaefer-Mcdaniel, M. Halman, and R. Grimes, “Causes of death in HIV patients and the evolution of an AIDS hospice: 1988–2008,” AIDS Research and Treatment, vol. 2012, Article ID 390406, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Rothenberg, M. Woelfel, R. Stoneburner, J. Milberg, R. Parker, and B. Truman, “Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City,” The New England Journal of Medicine, vol. 317, no. 21, pp. 1297–1302, 1987. View at Publisher · View at Google Scholar · View at Scopus
  6. J. H. Campbell, A. C. Hearps, G. E. Martin, K. C. Williams, and S. M. Crowe, “The importance of monocytes and macrophages in HIV pathogenesis,treatment,and cure,” AIDS, vol. 28, no. 15, pp. 2175–2187, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Eltom, A. Jemal, S. M. Mbulaiteye, S. S. Devesa, and R. J. Biggar, “Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998,” Journal of the National Cancer Institute, vol. 94, no. 16, pp. 1204–1210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Cattelan, M. L. Calabrò, P. Gasperini et al., “Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome,” Journal of the National Cancer Institute. Monographs, no. 28, pp. 44–49, 2001. View at Google Scholar
  9. G. Di Lorenzo, P. A. Konstantinopoulos, L. Pantanowitz, R. Di Trolio, S. De Placido, and B. J. Dezube, “Management of AIDS-related Kaposi's sarcoma,” The Lancet Oncology, vol. 8, no. 2, pp. 167–176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. S. Semeere, N. Busakhala, and J. N. Martin, “Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings,” Current Opinion in Oncology, vol. 24, no. 5, pp. 522–530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. S. E. Krown, “Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma,” Journal of Clinical Oncology, vol. 22, no. 3, pp. 399–402, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. E. L. Yanik, K. Tamburro, J. J. Eron, B. Damania, S. Napravnik, and D. P. Dittmer, “Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011,” Infectious Agents and Cancer, vol. 8, no. 1, article no. 18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Serraino, A. De Paoli, A. Zucchetto et al., “The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era,” Cancer Epidemiology, vol. 34, no. 3, pp. 257–261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Martín-Carbonero, R. Palacios, E. Valencia et al., “Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin,” Clinical Infectious Diseases, vol. 47, no. 3, pp. 410–417, 2008. View at Publisher · View at Google Scholar
  15. M. Bower, J. Weir, N. Francis et al., “The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma,” AIDS, vol. 23, no. 13, pp. 1701–1706, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. E. Krown, J. Y. Lee, and D. P. Dittmer, “More on HIV-associated Kaposi's sarcoma,” The New England Journal of Medicine, vol. 358, no. 5, pp. 535–536, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA—A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. E. A. Mesri, E. Cesarman, and C. Boshoff, “Kaposi's sarcoma and its associated herpesvirus,” Nature Reviews Cancer, vol. 10, no. 10, pp. 707–719, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Letang, J. J. Lewis, M. Bower et al., “Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK,” AIDS, vol. 27, no. 10, pp. 1603–1613, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Q. Nguyen, A. S. Magaret, M. M. Kitahata, S. E. Van Rompaey, A. Wald, and C. Casper, “Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response,” AIDS, vol. 22, no. 8, pp. 937–945, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Uccini, S. Scarpino, F. Ballarini et al., “In situ study of chemokine and chemokine-receptor expression in Kaposi sarcoma,” The American Journal of Dermatopathology, vol. 25, no. 5, pp. 377–383, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Dupin and P. A. Grange, “Looking for the target cell of Kaposi's sarcoma-associated herpesvirus,” The Journal of Investigative Dermatology, vol. 126, no. 3, pp. 545–547, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Ensoli, C. Sgadari, G. Barillari, M. C. Sirianni, M. Stürzl, and P. Monini, “Biology of Kaposi's sarcoma,” European Journal of Cancer, vol. 37, no. 10, pp. 1251–1269, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Delli Bovi, E. Donti, D. M. Knowles II et al., “Presence of chromosomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS-associated Kaposi's sarcoma,” Cancer Research, vol. 46, no. 12, part 1, pp. 6333–6338, 1986. View at Google Scholar · View at Scopus
  25. M. Salemi, S. L. Lamers, L. C. Huysentruyt et al., “Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-hodgkins Lymphoma,” PLoS ONE, vol. 4, no. 12, Article ID e8153, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. L. Lamers, M. Salemi, D. C. Galligan et al., “Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain,” Journal of NeuroVirology, vol. 16, no. 3, pp. 230–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. L. Lamers, M. Salemi, D. C. Galligan et al., “Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopathology,” PLoS ONE, vol. 4, no. 3, Article ID e5065, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Palmer, M. Kearney, F. Maldarelli et al., “Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis,” Journal of Clinical Microbiology, vol. 43, no. 1, pp. 406–413, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. J. D. Thompson, T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins, “The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools,” Nucleic Acids Research, vol. 25, no. 24, pp. 4876–4882, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Tamura, D. Peterson, N. Peterson, G. Stecher, M. Nei, and S. Kumar, “MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods,” Molecular Biology and Evolution, vol. 28, no. 10, pp. 2731–2739, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Guindon, F. Delsuc, J.-F. Dufayard, and O. Gascuel, “Estimating maximum likelihood phylogenies with PhyML,” Methods in Molecular Biology, vol. 537, pp. 113–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Slatkin and W. P. Maddison, “A cladistic measure of gene flow inferred from the phylogenies of alleles,” Genetics, vol. 123, no. 3, pp. 603–613, 1989. View at Google Scholar · View at Scopus
  33. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists,” Nucleic Acids Research, vol. 37, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Maldarelli, X. Wu, L. Su et al., “Specific HIV integration sites are linked to clonal expansion and persistence of infected cells,” Science, vol. 345, no. 6193, pp. 179–183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Shiramizu, B. Herndier, H. Abby, and M. S. McGrath, “Clonal HIV is present in a wide variety of HIV-associated malignancies and cell separation studies map the clone to tumor-associated macrophages,” Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, vol. 14, no. 4, article A50, 1997. View at Google Scholar
  36. M. S. McGrath, B. T. Shiramizu, and B. G. Herndier, “Identification of a clonal form of HIV in early Kaposi's sarcoma: evidence for a novel model of ontogenesis, ‘sequential neoplasia’,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 8, no. 4, pp. 379–385, 1995. View at Google Scholar · View at Scopus
  37. B. Shiramizu, B. G. Herndier, and M. S. McGrath, “Identification of a common clonal human immunodeficiency virus integration site in human immunodeficiency virus-associated lymphomas,” Cancer Research, vol. 54, no. 8, pp. 2069–2072, 1994. View at Google Scholar · View at Scopus
  38. K. D. Mack, X. Jin, S. Yu et al., “HIV insertions within and proximal to host cell genes are a common finding in tissues containing high levels of HIV DNA and macrophage-associated p24 antigen expression,” Journal of Acquired Immune Deficiency Syndromes, vol. 33, no. 3, pp. 308–320, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. R. S. Leidner and D. M. Aboulafia, “Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome,” AIDS Patient Care and STDs, vol. 19, no. 10, pp. 635–644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Letang, J. M. Almeida, J. M. Miró et al., “Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 5, pp. 589–597, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Müller, S. Wandel, R. Colebunders, S. Attia, H. Furrer, and M. Egger, “Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis,” The Lancet Infectious Diseases, vol. 10, no. 4, pp. 251–261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. S. A. Shelburne and R. J. Hamill, “The immune reconstitution inflammatory syndrome,” AIDS Reviews, vol. 5, no. 2, pp. 67–79, 2003. View at Google Scholar
  43. S. A. Shelburne III, R. J. Hamill, M. C. Rodriguez-Barradas et al., “Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy,” Medicine, vol. 81, no. 3, pp. 213–227, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. M. A. French, P. Price, and S. F. Stone, “Immune restoration disease after antiretroviral therapy,” AIDS, vol. 18, no. 12, pp. 1615–1627, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. S. F. Stone, P. Price, and M. A. French, “Immune restoration disease: a consequence of dysregulated immune responses after HAART,” Current HIV Research, vol. 2, no. 3, pp. 235–242, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Price, N. Mathiot, R. Krueger, S. Stone, N. M. Keane, and M. A. French, “Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy,” Journal of Clinical Virology, vol. 22, no. 3, pp. 279–287, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. N. F. Walker, N. F. Walker, N. F. Walker et al., “Immune reconstitution inflammatory syndrome in HIV-infected patients,” HIV/AIDS - Research and Palliative Care, vol. 7, pp. 49–64, 2015. View at Publisher · View at Google Scholar · View at Scopus